Walter Z Wang
Overview
Explore the profile of Walter Z Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang W, Shulman A, Amann J, Carbone D, Tsichlis P
Semin Cancer Biol
. 2022 Apr;
86(Pt 2):543-554.
PMID: 35398266
Small cell lung cancer (SCLC) is an extremely aggressive neuroendocrine tumor, accounting for approximated 13% of all lung cancer cases. SCLC is characterized by rapid growth and early metastasis. Despite...
2.
Rowbotham S, Goruganthu M, Arasada R, Wang W, Carbone D, Kim C
Cold Spring Harb Perspect Med
. 2021 Sep;
12(4).
PMID: 34580078
It is now widely accepted that stem cells exist in various cancers, including lung cancer, which are referred to as cancer stem cells (CSCs). CSCs are defined in this context...
3.
Wang W, Shilo K, Amann J, Shulman A, Hojjat-Farsangi M, Mellstedt H, et al.
Cell Death Dis
. 2021 Jun;
12(6):577.
PMID: 34088900
Small cell lung cancer (SCLC) remains a deadly form of cancer, with a 5-year survival rate of less than 10 percent, necessitating novel therapies. Receptor tyrosine kinase-like orphan receptor 1...
4.
Koenig M, Agana B, Kaufman J, Sharpnack M, Wang W, Weigel C, et al.
Cancer Res
. 2021 May;
81(16):4194-4204.
PMID: 34045189
STK11 (liver kinase B1, LKB1) is the fourth most frequently mutated gene in lung adenocarcinoma, with loss of function observed in up to 30% of all cases. Our previous work...
5.
Walter D, Yates T, Ruiz-Torres M, Kim-Kiselak C, Gudiel A, Deshpande C, et al.
Nature
. 2019 May;
569(7756):423-427.
PMID: 31043741
Mutations in the retinoblastoma (RB) tumour suppressor pathway are a hallmark of cancer and a prevalent feature of lung adenocarcinoma. Although RB was the first tumour suppressor to be identified,...
6.
Wang D, Jones A, Wang W, Wang M, Korthuis R
Am J Physiol Gastrointest Liver Physiol
. 2016 Mar;
310(9):G747-56.
PMID: 26950856
The aim was to determine whether treatment with BAY 60-2770, a selective activator of oxidized soluble guanylate cyclase (sGC), near the end of an ischemic event would prevent postischemic inflammation...
7.
Wang W, Jones A, Wang M, Durante W, Korthuis R
Am J Physiol Heart Circ Physiol
. 2013 Jun;
305(4):H521-32.
PMID: 23771693
Previously we have shown that, unlike wild-type mice (WT), heme oxygenase-1 knockout (HO-1-/-) mice developed nitrate tolerance and were not protected from inflammation caused by ischemia-reperfusion (I/R) when preconditioned with...